The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 ...

The Food and Drug Administration is warning consumers about a voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to an incorrect drug in the bottles. According to the FDA, sealed ...

The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable ...

Camber Pharmaceuticals issued a voluntary recall of one lot of its Montelukast sodium tablets after the bottles were found to contain the wrong drug. The sealed bottles were supposed to contain 30 ...

The risk of a mixing-up the treatments is especially high for pregnant women, says the Food and Drug Administration (FDA), as losartan is indicated to treat high blood pressure and could harm or kill ...

Camber Pharmaceuticals is recalling one lot of montelukast sodium tablets because the bottles are labeled "montelukast sodium tablets, 10-mg, 30-count" but actually contain 90 tablets of losartan ...

Dr. Reddy’s Laboratories (RDY) has launched Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets, bioequivalent generic versions of SINGULAIR (MRK) Tablets and Chewable tablets, in the ...

PITTSBURGH, Aug. 7, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) ...

KENILWORTH and WHITEHOUSE STATION, N.J., Aug. 28 -- Schering-Plough/Merck Pharmaceuticals (SPM) today announced that the New Drug Application filing for loratadine/montelukast has been accepted by the ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium Tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable ...